Patents-Review.com
🔗 Permalink
Assignee profile:

DEXCEL PHARMA TECHNOLOGIES LTD.

City:

Or- Akiva

Country:

Israel

Published Applications:

25

Last publication date:

2022-04-28

Patent Grants:

16

Last grant date:

2024-05-21

Top Inventors for applications by DEXCEL PHARMA TECHNOLOGIES LTD.

These are the the leading inventors for applications assigned to DEXCEL PHARMA TECHNOLOGIES LTD.:

Recent patent applications by DEXCEL PHARMA TECHNOLOGIES LTD.

DEXCEL PHARMA TECHNOLOGIES LTD. based in Or- Akiva, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-04-28
US20220125730A1
Human necessities

METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET

 #2 | 2022-02-03
US20220031622A1
Human necessities

STABLE BENZIMIDAZOLE FORMULATION

 #3 | 2021-11-18 ✅ Patent 11,986,554 granted on 2024-05-21
US20210353535A1
Human necessities

Orally disintegrating compositions

 #4 | 2021-01-14 ✅ Patent 11,299,583 granted on 2022-04-12
US20210009751A1
Chemistry; metallurgy

Alternating and semi-alternating poly(ester-anhydride) copolymers

 #5 | 2020-08-27 ✅ Patent 11,096,948 granted on 2021-08-24
US20200268769A1
Human necessities

Methods for treating infection

 #6 | 2020-05-14 ✅ Patent 11,304,961 granted on 2022-04-19
US20200147106A1
Human necessities

Compositions comprising dexamethasone

 #7 | 2020-04-02 ✅ Patent 11,141,488 granted on 2021-10-12
US20200101163A1
Human necessities

Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic

 #8 | 2019-07-11
US20190209466A1
Human necessities

OPHTHALMIC COMPOSITIONS

 #9 | 2019-06-20 ✅ Patent 10,537,585 granted on 2020-01-21
US20190183907A1
Human necessities

Compositions comprising dexamethasone

 #10 | 2019-05-02
US20190125792A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF

 #11 | 2019-05-02
US20190125676A1
Human necessities

COMPOSITIONS COMPRISING PROTON PUMP INHIBITORS FOR ORAL ADMINISTRATION

 #12 | 2019-02-14 ✅ Patent 10,736,855 granted on 2020-08-11
US20190046457A1
Human necessities

Compositions comprising proton pump inhibitors

 #13 | 2019-01-10 ✅ Patent 10,835,488 granted on 2020-11-17
US20190008767A1
Human necessities

Stable orally disintegrating pharmaceutical compositions

 #14 | 2018-09-27
US20180271790A1
Human necessities

STABLE BENZIMIDAZOLE FORMULATION

 #15 | 2018-02-15 ✅ Patent 10,774,176 granted on 2020-09-15
US20180043026A1
Human necessities

Alternating and semi-alternating poly(ester-anhydride) copolymers

 #16 | 2017-12-21 ✅ Patent 10,076,494 granted on 2018-09-18
US20170360697A1
Human necessities

Stable orally disintegrating pharmaceutical compositions

 #17 | 2017-04-20 ✅ Patent 10,172,882 granted on 2019-01-08
US20170106018A1
Human necessities

Pharmaceutical compositions comprising ferric citrate and methods for the production thereof

 #18 | 2017-02-16
US20170042806A1
Human necessities

ORALLY DISINTEGRATING COMPOSITIONS

 #19 | 2016-12-08 ✅ Patent 11,077,055 granted on 2021-08-03
US20160354356A1
Human necessities

Orally disintegrating compositions

 #20 | 2016-06-09 ✅ Patent 9,889,090 granted on 2018-02-13
US20160158148A1
Human necessities

Method for treating a periodontal disease

 #21 | 2015-01-22 ✅ Patent 9,278,064 granted on 2016-03-08
US20150024021A1
Human necessities

Method for treating a periodontal disease

 #22 | 2014-10-23
US20140314846A1
Human necessities

MULTIPLE UNIT PHARMACEUTICAL FORMULATION

 #23 | 2014-06-26
US20140178469A1
Human necessities

STABLE BENZIMIDAZOLE FORMULATION

 #24 | 2012-04-26 ✅ Patent 8,865,198 granted on 2014-10-21
US20120100199A1
Human necessities

Method for treating a periodontal disease

 #25 | 2011-09-29 ✅ Patent 9,757,338 granted on 2017-09-12
US20110237623A1
Human necessities

Sustained-release donepezil formulation

Also check out DEXCEL PHARMA TECHNOLOGIES LTD.'s (Or-Akiva, Israel) applicant profile with 13 patent applications submitted.

AssigneeID:

69423 ⎘